デフォルト表紙
市場調査レポート
商品コード
1489498

遠心分離機の世界市場-2024-2031

Global Centrifuge Market - 2024-2031


出版日
ページ情報
英文 210 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
遠心分離機の世界市場-2024-2031
出版日: 2024年06月05日
発行: DataM Intelligence
ページ情報: 英文 210 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界の遠心分離機市場は2023年に101億米ドルに達し、2031年には144億米ドルに達すると予測され、予測期間2024-2031年のCAGRは4.5%で成長する見込みです。

医薬品規制政策の改善、臨床研究の標準化、償還政策の修正に向けた各国の政府の取り組みが、業界の拡大に寄与しています。さらに、発売される技術的に高度な実験用遠心分離機の数が増加していることも、予測期間中に実験用遠心分離機市場が発展するための有益な機会となっています。

新製品のイントロダクションでは、小型化・可搬性、速度・加速度の向上、高度な冷却システム、自動化・ロボットとの統合など、最先端の技術革新が頻繁に組み込まれています。例えば、クボタは2021年4月に卓上型遠心分離機「Model S500T」と床置き型冷凍遠心分離機「Model S500FR」を発表しました。これらの機種には、「セルフチェック機能」、「不均衡早期検出機能」、「混載バケット」、「3年保証」などの革新的で安全な制御機能が搭載されています。

2023年には、北米が世界の遠心分離機市場の35%以上を占める主要地域になると予想されています。化学産業が同地域の遠心分離機市場に大きく貢献しているため、市場は新興国市場に発展しています。米国化学工業協会は、2022年の化学工業の世界総売上高が5兆7,200億米ドルになると推定しています。2022年、化学部門の売上高は過去15年間で最高値を達成しました。

ダイナミクス

ヘルスケアにおける診断の進歩

遠心分離は、血液成分、尿沈渣、その他の生理的体液を分離するために臨床検査室で不可欠なプロセスです。慢性疾患や感染症の増加により、信頼性の高い迅速な診断情報は最適な患者ケアに不可欠です。遠心分離機の設計技術は進歩し、処理時間が短縮され、サンプル処理能力が向上し、使い勝手が向上した装置が開発されています。

さらに、遠心分離機をフローサイトメトリーや分子診断などの他の診断技術と統合することで、患者サンプルの徹底的かつ多角的な研究が可能になります。ヘルスケア業界では、疾患の早期発見と個別化治療技術が重視される傾向にあるため、診断精度と効率を高める高度な遠心分離機に対する需要は、依然として市場の主要促進要因となっています。

バイオテクノロジーと医薬品研究の成長

これらの産業は技術革新の中心であり、疾病の理解を深め、新規治療を開発し、ヘルスケアの成果を高めるための新しい方法を絶えず模索しています。遠心分離機は、多数の生物学的成分の正確な分離、単離、研究を可能にするため、これらの活動において重要な役割を果たしています。バイオテクノロジーの分野では、科学者は複雑な生物学的プロセス、タンパク質の相互作用、遺伝システムを研究しています。

遠心分離機は、遠心力を利用して質量と密度に基づいて物質を分離することにより、このようなニーズに応えています。ゲノミクス、プロテオミクス、分子生物学などの分野では、核酸、タンパク質、細胞小器官を分離することが、疾患経路の解明や標的治療薬の開発に不可欠です。

高いコストと規制

遠心分離機は、特に研究、バイオテクノロジー、製薬の用途で使用される高速で特殊なタイプのものは、購入コストが高くつくことがあります。遠心分離機の高額な初期費用は、この機器への投資を思いとどまらせる研究室、学術機関、小規模企業、特に予算や財政的制約の厳しい研究室もあるかもしれないです。

当初の出費は別として、遠心分離機の運転には、エネルギー消費、メンテナンス、チューブやローターなどの消耗品のために費用がかかることがあります。特に経営資源が限られている企業では、経常的な出費が財政の負担になるかもしれないです。遠心分離機の使用は、特にヘルスケアやバイオテクノロジーにおいて規制の対象となる場合があります。規格や法律の遵守は、ユーザーにとって管理上の手間や経費を増加させ、採用や使用に影響を及ぼす可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • ヘルスケアにおける診断の進歩
      • バイオテクノロジーと医薬品研究の成長
    • 抑制要因
      • 高いコストと規制
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品別

  • 装置
    • 多目的遠心分離機
    • 微量遠心分離機
    • 超遠心分離機
    • その他
  • 付属品
    • ローター
    • チューブ
    • バケット
    • その他

第8章 モデル別

  • 卓上型
  • 床置き型

第9章 ローターデザイン別

  • 固定アングル
  • スイングバケット
  • 縦型
  • その他

第10章 運転モード

  • バッチ運転
  • 連続運転

第11章 エンドユーザー別

  • 病院・血液バンク
    • 臨床
    • 調査
    • その他
  • バイオテクノロジーと製薬
    • 臨床
    • 調査
    • バイオ治療薬製造
    • その他
  • 石油
  • 化学品
  • 飲食品
  • 上下水道治療
  • 金属・鉱業
  • 電力
  • パルプ・製紙
  • その他

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第14章 企業プロファイル

  • Thermo Fisher Scientific Inc.
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Sartorius AG
  • Eppendorf AG
  • QIAGEN
  • Kubota Corporation
  • NuAire
  • Sigma Laborzentrifugen GmbH
  • Andreas Hettich GmbH & Co. KG

第15章 企業概要付録

目次
Product Code: CH8675

Overview

Global Centrifuge Market reached US$ 10.1 billion in 2023 and is expected to reach US$ 14.4 billion by 2031, growing with a CAGR of 4.5% during the forecast period 2024-2031.

Government efforts in various nations to improve medicine regulatory policies, standardize clinical research and modify reimbursement policies are helping to expand the industry. Furthermore, the increasing number of technologically advanced laboratory centrifuges being launched presents a profitable opportunity for the laboratory centrifuge market to develop during the forecast period.

New product introductions frequently integrate cutting-edge technological innovations like downsizing & portability, increased speed & acceleration, advanced cooling systems and integration with automation and robots. For example, in April 2021, Kubota Corporation introduced the Benchtop Centrifuge Model S500T and the Floor Standing Refrigerated Centrifuge Model S500FR. The models contain innovative and safe control functions like "Self-Check Function", "Imbalance Early Detector", "Mixed-loading buckets" and "3-year warranty".

In 2023, North America is expected to be the dominant region with over 35% of the global Centrifuge market. The market is developing as the chemical industry contributes significantly to the region's centrifuges market. The American Chemistry Council estimates that the chemical industry's total global sales will be US$ 5.72 trillion in 2022. In 2022, the chemical sector revenue achieved its highest value in the previous 15 years.

Dynamics

Diagnostic Advancements in Healthcare

Centrifugation is an essential process in clinical laboratories for separating blood components, urine sediments and other physiological fluids. With the increasing prevalence of chronic diseases and infections, reliable and fast diagnostic information is critical for optimal patient care. Centrifuge design technology has advanced, resulting in equipment with faster processing times, better sample handling capabilities and more ease of use.

Furthermore, integrating centrifuges with other diagnostic technologies, such as flow cytometry and molecular diagnostics, allows for thorough and multidimensional study of patient samples. As the healthcare industry tends to emphasize early disease identification and individualized treatment techniques, the demand for advanced centrifuges that boost diagnostic accuracy and efficiency remains a major market driver.

Growing Biotechnology and Pharmaceutical Research

The industries are at the centre of innovation, continuously looking for new ways to better understand diseases, develop novel treatments and enhance healthcare outcomes. Centrifuges play an important part in these activities because they allow for the accurate separation, isolation and study of numerous biological components. In the field of biotechnology, scientists are studying complex biological processes, protein interactions and genetic systems.

Centrifuges meet these needs by using centrifugal force to separate substances based on mass and density. It is necessary for research in domains such as genomics, proteomics and molecular biology, where separating nucleic acids, proteins and organelles is vital for gaining insights into disease pathways and generating targeted therapeutics.

High Costs and Regulations

Centrifuge equipment can be costly to purchase, especially high-speed and specialized types used in research, biotechnology and pharmaceutical applications. Centrifuges' high initial cost may dissuade some laboratories, academic institutions and small enterprises from investing in this equipment, especially those with tight budgets or financial constraints.

Aside from the original expenditure, operating centrifuges can be costly due to energy consumption, maintenance and consumables such as tubes and rotors. The recurring expense might put a burden on finances, especially in businesses with limited resources. Centrifuge use may be subject to regulatory regulations, especially in healthcare and biotechnology. Compliance with standards and laws can increase administrative hassles and expenses for users, affecting adoption and use.

Segment Analysis

The global centrifuge market is segmented based on product, model, rotor design, operation mode, end-user and region.

Rising Demand of Chemicals Drives the Segment Growth

Biotechnology & pharmaceutical is expected to be the dominant segment with over 30% of the market during the forecast period 2024-2031. As chemical processing capacity increases, there is a greater demand for separation and purification technologies such as centrifuges to handle bigger volumes of chemicals while maintaining product quality and purity. As a result, centrifuge producers will benefit from increased prospects in the globally chemical industry.

Rising global demand for chemicals in a variety of industries, including pharmaceuticals and biotechnology, is driving infrastructure investments to satisfy growing production demands. For example, in September 2023, Sichuan Hebang Biotechnology Co. declared an investment of US$ 800 million to build a chemical production facility at the Java Integrated Industrial and Port Estate. Upon completed, the facility will have a yearly output of 600,000 tons of sodium carbonate and ammonium chloride, with a glyphosate production capacity estimated to be 200,000 tons.

Geographical Penetration

Rising Demand from Various End-User Industries in Asia-Pacific

Asia-Pacific is expected to be t he fastest growing region in the global centrifuge market covering over 20% of the market. Asia-Pacific is one of the fastest expanding centrifuge markets, owing to China's dominance in the chemical and industrial, pharmaceutical and wastewater treatment industries. Furthermore, nations such as India, Indonesia and Malaysia are experiencing tremendous growth in energy demand as a result of increased industrial activity.

China's National Energy Administration is considering boosting the scope of the country's clean energy programs this decade. The NEA recommends that China obtain 40% of its electricity through nuclear and renewable sources by 2031, with a nuclear capacity target of 120-150 gigawatts by 2031. Such government policies and aims assist the nation's growth of nuclear power plants in the coming years and are expected to generate chances for the centrifuges industry.

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Sartorius AG, Eppendorf AG, QIAGEN, Kubota Corporation, NuAire, Sigma Laborzentrifugen GmbH and Andreas Hettich GmbH & Co. KG.

COVID-19 Impact Analysis

The pandemic impacted globally supply networks, including centrifuge manufacturing. Movement restrictions, border closures and lockdown procedures caused delays in the transit of raw materials, components and final products. The caused supply shortages and production delays for centrifuge producers, limiting their capacity to meet client demand. The epidemic caused interruptions or slowdowns in several businesses that use centrifuges, including academic research, biotechnology and pharmaceuticals.

Research facilities were temporarily stopped, clinical studies were delayed and non-essential medical procedures were rescheduled, resulting in lower demand for centrifuges in these industries. The pandemic-induced economic slowdown has had an impact on government funding for research programs and academic institutions. Budget cuts and resource reallocation resulted in lower investment on research equipment, such as centrifuges. The impacted centrifuge sales to research institutions and universities.

Russia-Ukraine War Impact

Russia and Ukraine are major suppliers of raw materials, components and machinery for centrifuge manufacturing. Any production or shipping problems caused by the conflict resulted in supply shortages or delays in the globally centrifuge market. It impacted the supply of centrifuge components, spare parts and equipment, disrupting global manufacturing operations and delivery timelines.

The dispute between Russia and Ukraine has globally consequences, including the oil, gas and nuclear energy industries. Centrifuges are employed in a variety of energy-related activities, including as oil and gas drilling, refining and nuclear power generation. Changes in energy supply chains or changes in energy regulations stemming from the conflict affected demand for centrifuges and related equipment.

By Product

  • Equipment
    • Multipurpose Centrifuge
    • Microcentrifuges
    • Ultracentrifuges
    • Others
  • Accessories
    • Rotors
    • Tubes
    • Buckets
    • Others

By Model

  • Benchtop
  • Floor-Standing

By Rotor Design

  • Fixed-angle
  • Swinging-Bucket
  • Vertical
  • Others

By Operation Mode

  • Batch
  • Continuous

By End-User

  • Hospitals & Blood Banks
    • Clinical
    • Research
    • Others
  • Biotechnology & Pharmaceutical
    • Clinical
    • Research
    • Biotherapeutic Manufacturing
    • Others
  • Oil and Petroleum
  • Chemicals
  • Food & Beverages
  • Water and Wastewater Treatment
  • Metal & Mining
  • Power
  • Pulp & Paper
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2024, GEA launched X Control, a new centrifuge control system. The introduction of X Control paves the way for the integration of Artificial Intelligence, which promises faster and simpler data collecting and analysis, as well as self-optimization of the entire system in the future. Increased processing capabilities will also improve collaboration with Supervisory Control and Data Acquisition systems.
  • In September 2023, U.S. Army Engineer Research and Development Center conducted an overhaul of beam centrifuges, modernizing one of the most inventive pieces of technology. The centrifuge in the Geotechnical and Structures Laboratory's Geotechnical Engineering and Geosciences Branch has been upgraded with enhancements to its electrical and hydraulic systems and extensive renovations to the control building.

Why Purchase the Report?

  • To visualize the global centrifuge market segmentation based on product, model, rotor design, operation mode, end-user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of centrifuge market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global centrifuge market report would provide approximately 78 tables, 77 figures and 210 pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Product
  • 3.2.Snippet by Model
  • 3.3.Snippet by Rotor Design
  • 3.4.Snippet by Operation Mode
  • 3.5.Snippet by End-User
  • 3.6.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Diagnostic Advancements in Healthcare
      • 4.1.1.2.Growing Biotechnology and Pharmaceutical Research
    • 4.1.2.Restraints
      • 4.1.2.1.High Costs and Regulations
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.Russia-Ukraine War Impact Analysis
  • 5.6.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID-19
    • 6.1.2.Scenario During COVID-19
    • 6.1.3.Scenario Post COVID-19
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Product

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2.Market Attractiveness Index, By Product
  • 7.2.Equipment*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3.Multipurpose Centrifuge
    • 7.2.4.Microcentrifuges
    • 7.2.5.Ultracentrifuges
    • 7.2.6.Others
  • 7.3.Accessories
    • 7.3.1.Rotors
    • 7.3.2.Tubes
    • 7.3.3.Buckets
    • 7.3.4.Others

8.By Model

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
    • 8.1.2.Market Attractiveness Index, By Model
  • 8.2.Benchtop*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Floor-Standing

9.By Rotor Design

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
    • 9.1.2.Market Attractiveness Index, By Rotor Design
  • 9.2.Fixed-angle*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Swinging-Bucket
  • 9.4.Vertical
  • 9.5.Others

10.Operation Mode

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
    • 10.1.2.Market Attractiveness Index, By Operation Mode
  • 10.2.Batch*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Continuous

11.End-User

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.1.2.Market Attractiveness Index, By End-User
  • 11.2.Hospitals & Blood Banks*
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 11.2.3.Clinical
    • 11.2.4.Research
    • 11.2.5.Others
  • 11.3.Biotechnology & Pharmaceutical
    • 11.3.1.Clinical
    • 11.3.2.Research
    • 11.3.3.Biotherapeutic Manufacturing
    • 11.3.4.Others
  • 11.4.Oil and Petroleum
  • 11.5.Chemicals
  • 11.6.Food & Beverages
  • 11.7.Water and Wastewater Treatment
  • 11.8.Metal & Mining
  • 11.9.Power
  • 11.10.Pulp & Paper
  • 11.11.Others

12.By Region

  • 12.1.Introduction
    • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2.Market Attractiveness Index, By Region
  • 12.2.North America
    • 12.2.1.Introduction
    • 12.2.2.Key Region-Specific Dynamics
    • 12.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
    • 12.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
    • 12.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
    • 12.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1.U.S.
      • 12.2.8.2.Canada
      • 12.2.8.3.Mexico
  • 12.3.Europe
    • 12.3.1.Introduction
    • 12.3.2.Key Region-Specific Dynamics
    • 12.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
    • 12.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
    • 12.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
    • 12.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1.Germany
      • 12.3.8.2.UK
      • 12.3.8.3.France
      • 12.3.8.4.Italy
      • 12.3.8.5.Russia
      • 12.3.8.6.Rest of Europe
  • 12.4.South America
    • 12.4.1.Introduction
    • 12.4.2.Key Region-Specific Dynamics
    • 12.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
    • 12.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
    • 12.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
    • 12.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1.Brazil
      • 12.4.8.2.Argentina
      • 12.4.8.3.Rest of South America
  • 12.5.Asia-Pacific
    • 12.5.1.Introduction
    • 12.5.2.Key Region-Specific Dynamics
    • 12.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
    • 12.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
    • 12.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
    • 12.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1.China
      • 12.5.8.2.India
      • 12.5.8.3.Japan
      • 12.5.8.4.Australia
      • 12.5.8.5.Rest of Asia-Pacific
  • 12.6.Middle East and Africa
    • 12.6.1.Introduction
    • 12.6.2.Key Region-Specific Dynamics
    • 12.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Model
    • 12.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Rotor Design
    • 12.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Mode
    • 12.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13.Competitive Landscape

  • 13.1.Competitive Scenario
  • 13.2.Market Positioning/Share Analysis
  • 13.3.Mergers and Acquisitions Analysis

14.Company Profiles

  • 14.1.Thermo Fisher Scientific Inc.*
    • 14.1.1.Company Overview
    • 14.1.2.Product Portfolio and Description
    • 14.1.3.Financial Overview
    • 14.1.4.Key Developments
  • 14.2.Danaher Corporation
  • 14.3.Becton, Dickinson and Company
  • 14.4.Sartorius AG
  • 14.5.Eppendorf AG
  • 14.6.QIAGEN
  • 14.7.Kubota Corporation
  • 14.8.NuAire
  • 14.9.Sigma Laborzentrifugen GmbH
  • 14.10.Andreas Hettich GmbH & Co. KG

LIST NOT EXHAUSTIVE

15.Appendix

  • 15.1.About Us and Services
  • 15.2.Contact Us